Introducing New Prostate Cancer Treatment, Available from BioPlus

    A new medication has joined the ranks of potential treatment for prostate cancer. The FDA recently...

    Read More >>

    Crohn’s Disease: Heading Toward its 100th Birthday

    Could a cure for Crohn’s disease be in the future? There are several research directions that are...

    Read More >>

    Manly MS Resistance?

    Multiple sclerosis is often thought of as more of a female disease. This is because women are...

    Read More >>

    Hepatitis C and Diabetes: A Complicated Relationship

    Guest blog by:  Erica Yelton, Pharm.D., CSP, Pharmacy Center Manager, BioPlus Specialty Pharmacy

    ...

    Read More >>

    The Prostate Cancer Toolkit

    For men, prostate cancer remains the second most common type of cancer. Only skin cancer is more...

    Read More >>

    Personalizing Crohn’s Disease Treatment

    Guest blog by: Marianne Shenouda, Pharm.D., Clinical Pharmacy Specialist, BioPlus Specialty...

    Read More >>

    Rheumatoid Arthritis: What Should I Eat?

    When it comes to rheumatoid arthritis, the foods one eats or avoids can actually affect the...

    Read More >>

    Energy Drink Ingredient’s Surprising Role in Multiple Sclerosis

    The amino acid taurine has caught the attention of multiple sclerosis researchers. Amino acids are...

    Read More >>

    HCV and Children

    Hepatitis C screening programs and treatment outreach tend to focus on three key populations: Baby...

    Read More >>

    Breast Cancer Treatment Options Expanding

    Targeted cancer therapies aim to best match the treatment to specific characteristics of cancer...

    Read More >>

    The Rheumatoid Arthritis Gender Gap

    Rheumatoid arthritis skews very female in the 1.5 million Americans with this disease. There are...

    Read More >>

    A Faster Route to Treatment

    Psoriasis goes more than skin deep. Although primarily thought of as a skin disease, psoriasis...

    Read More >>

    A Look Back at 2017’s FDA Approvals

    2018 is poised to be a promising year in terms of new medications the U.S. Food and Drug...

    Read More >>